Study S000808

Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes: THE STENO INTEN-CT STUDY

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)

Registration

Registration: NCT05700877
Acronym: STENO INTEN-CT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: RECRUITING
Enrollment: 7300
Start: 2023-01-12
Primary completion: 2029-01-01
Lead sponsor: Per Løgstrup Poulsen
Conditions: Type 2 Diabetes; Cardiovascular Diseases
Interventions: OTHER:CAC-based treatment strategy; OTHER:Standard treatment
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Rates of a composite cardiovascular endpoint [Event-driven, expected mean follow-up of 5 years]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0007244	Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events? Funck KL, BMJ open	2025	Protocol	PMID 41401988 DOI	cites ClinicalTrials.gov:NCT05700877; registry reference DERIVED:41401988